Talk:Antiplatelet drug
 | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
| |||||||||||||||||||||
 | This article was created or improved by the University of Dundee Oral Health Wikipedia Group in 2016. |
Price?
I deleted the following sentence:
Further, "...the cost to prevent one major GI bleeding episode from aspirin in 1 year by substituting clopidogrel therapy would be $1,216,180..."
Putting a calulation on GI Bleeding seems to indicate that there is a savings by using Plavix. This would have to include a detailed analysis of the cost of the drug and the cost of side effects from the drug vs. the cost of asprin and the side effects from asprin.
The sentence seemed to indicate that there were no peripheral cost associated with the use of an antiplatelets. As there are side-effects with antiplatelets there are also additional cost. Qualifying these cost would be too distractive from the topic. Jeffjacks7 03:08, 22 March 2007 (UTC)
Resistance
doi:10.1136/heartjnl-2013-304461 something like 30% of all people on antiplatelets are resistant, and the outcomes are better once antiplatelets are tailored to their response.
Now we need a cost-effectiveness assessment, and platelet function testing is going to enter widespread use. JFW | T@lk 17:06, 11 December 2013 (UTC)